
Tim Mustill and Jenny Hepburn join InterPhase
pharmafile | April 18, 2011 | Appointment | Sales and Marketing | appointment, sales and marketing
KnowledgePoint360 Group has appointed Tim Mustill and Jennifer Hepburn to key positions within its strategic consulting practice InterPhase.
Tim has been named VP of strategic services and Jenny Hepburn joins as strategic consultant.
He said: “With InterPhase and KnowledgePoint360, we have the expertise to develop effective and innovative solutions to our clients’ commercialisation and strategic challenges, challenges which are increasingly complex in our rapidly changing environment.”
Tim joined KnowledgePoint360 in May 2010 and has over 25 years’ experience in pharma having held a number of senior commercial positions in the consultancy and communications arena.
Jenny has over 13 years’ experience in the industry in global marketing and consultancy roles including at AstraZeneca, where she led the development of global brand strategies.
She most recently served with the 7.4 marketing consultancy working on a wide range of strategic positioning and brand development initiatives.
“Tim and Jenny bring to the InterPhase team extensive, real world experience in dealing with the challenges of commercialising pharmaceuticals,” said Shaun Chilton, president of InterPhase.
Related Content

David Wheadon appointed to board of directors at Seaport Therapeutics
This week, Seaport Therapeutics have appointed David Wheadon MD to their board of directors.

Myeloma UK reveals new Director of Research appointment
UK non-profit organisation Myeloma UK has selected Sarah McDonald as its new Director of Research, …

Abbott CEO to step down after 21 years
After more than two decades at the head of the company, it has emerged that …






